Effects of ECT on pituitary hormone release: relationship to seizure, clinical variables and outcome

J F Deakin, I N Ferrier, T J Crow, Eve C. Johnstone, P Lawler

Research output: Contribution to journalArticlepeer-review

Abstract

Prolactin, cortisol, growth hormone and TSH serum levels (before and 15 minutes after treatment) were measured in 62 patients with endogenous depression randomly allocated to real or pseudo-ECT. Prolactin increased significantly more in those receiving real ECT than in those receiving pseudo-ECT, but the size of this effect had diminished by the time of the last (8th) treatment in the trial. Cortisol secretion was also significantly increased following the first treatment by real ECT, but this increase was of significantly smaller size in patients with delusions. Tolerance to the effects of ECT on cortisol secretion was not observed. No effects of ECT on growth hormone or TSH secretion were detected, and no clear evidence was obtained that endocrine responses can be used as a predictor of response to ECT.

Original languageEnglish
Pages (from-to)618-24
Number of pages7
JournalThe British journal of psychiatry : the journal of mental science
Volume143
Publication statusPublished - Dec 1983

Keywords

  • Depressive Disorder
  • Electroconvulsive Therapy
  • Growth Hormone
  • Humans
  • Hydrocortisone
  • Pituitary Hormones
  • Prolactin
  • Thyrotropin
  • Clinical Trial
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

Fingerprint

Dive into the research topics of 'Effects of ECT on pituitary hormone release: relationship to seizure, clinical variables and outcome'. Together they form a unique fingerprint.

Cite this